Cross-cultural adaptation and validation of Haem-A-QoL in Côte d'Ivoire.


Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
May 2020
Historique:
received: 20 12 2019
revised: 10 03 2020
accepted: 16 03 2020
pubmed: 13 5 2020
medline: 15 12 2020
entrez: 13 5 2020
Statut: ppublish

Résumé

Health-related quality (HRQoL) evaluations are considered essential outcomes in the assessment of people with haemophilia. In developing countries, reliable HRQoL data are even more critical whilst enabling government agencies to develop national haemophilia care programmes. However, validated tools are not yet available in sub-Saharan African countries. This study sought to perform a cultural adaptation and validation of the Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL) in Côte d'Ivoire. The process comprised several steps, such as linguistic adaptation, cognitive debriefing interviews with adult haemophilia patients and psychometric testing, including reliability (internal consistency, test-retest reliability) and validity assessments (convergent with EQ-5D-5L, criterion with HJHS 2.1, known-groups). The final Ivoirian Haem-A-QoL version was obtained in December 2017 following linguistic adaptation and cognitive debriefings with six participants. The validation process included 25 patients, mainly haemophilia A patients (88%) with severe forms (80%). All participants received on-demand treatment, with joint impairment observed in 92%. Internal consistency and test-retest reliability of the Ivoirian Haem-A-QoL were very good. A Pearson correlation analysis revealed a moderate negative correlation between EQ-VAS and total Haem-A-QoL scores and a moderate positive correlation between HJHS 2.1 and total Haem-A-QoL scores. A cross-culturally adapted and validated Haem-A-QoL version in Côte d'Ivoire is now available, enabling measurement of intervention outcomes in the targeted population and Ivorian participation to multisite international trials. However, further work is needed to ensure optimal understanding of HRQoL questionnaires, previously developed in culturally distinct countries, with almost unlimited access to different treatment regimens.

Identifiants

pubmed: 32394627
doi: 10.1111/hae.13987
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-466

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Mannucci P, Tuddenham E. Medical progress. The hemophilias - from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773-1779.
White GC. Definitions in hemophilia. Recommandations of the scientific subcommittee of factor VIII and IX of the scientific standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85(03):560.
Boehlen F, Graf L, Berntorp E. Outcome measures in haemophilia: a systematic review. Eur J Haematol. 2014;93(S76):2-15.
Fischer K, Van der Bom JG, van den Berg H. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia. 2003;9(Suppl 1):75-81; discussion 82.
Limperg P, Terwee C, Young N, et al. Health-related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement properties. Haemophilia. 2017;23(4):497-510.
Aledort L, Bullinger M, von Mackensen S, Wasserman J, Young NL, Globe D. Why should we care about quality of life in persons with haemophilia? Haemophilia. 2012;18(3):e154-e157.
von Mackensen S, Campos I, Acquadro C, Strandberg-Larsen M. Cross-cultural adaptation and linguistic validation of age-group-specific haemophilia patient-reported outcome (PRO) instruments for patients and parents. Haemophilia. 2013;19(2):e73-e83.
Young N, St-Louis J, Burke T, Hershon L, Blanchette V. Cross-cultural validation of the CHO-KLAT and HAEMO-QoL in Canadian French. Haemophilia. 2012;18(3):353-357.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-1432.
Beaton D, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186-3191.
Acquadro C, Conway K, Hareendran A, Aaronson N. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Heal. 2008;11(3):509-521.
von Mackensen S, Gringeri A. Quality of life in hemophilia. In: Preedy VR, Watson RR, eds. Handbook of disease burdens and quality of life measures. New York, NY: Springer; 2010:1895-1920.
von Mackensen S, Eldar-Lissai A, Auguste P, et al. Measurement properties of the Haem-A-QoL in haemophilia clinical trials. Haemophilia. 2017;23(3):383-391.
von Mackensen S, Gringeri A, Ravera S. Validation of the haemophilia-specific quality of life questionnaire for adult patients with haemophilia (Haem-A-QoL). Haematologica. 2005;20(Suppl 2):115-116. Abstract 0290.
https://eprovide.mapi-trust.org/instruments/haemophilia-quality-of-life-questionnaire-for-adults#member_access_content. Accessed October 12, 2019.
Lambert C, Meité N, Sanogo I, et al. Cross-cultural adaptation of a Quality of Life measure (CHO-KLAT) for boys with haemophilia in the Ivory Coast. Health Qual Life Outcomes. 2020;18(1):76.
World Federation of Hemophilia (WFH). World Federation of Hemophilia Report on the annual Global Survey 2017; 2018. http://www1.wfh.org/publications/files/pdf-1714.pdf. Accessed October 12, 2019.
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.
Feldman B, Funk S, Bergstrom B, et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res. 2011;63(2):223-230.
Buckner T, Wang M, Cooper D, Iyer NN, Kempton CL. Known-Group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the pain, functional impairment, and quality of life (P-FiQ) study. Patient Prefer Adherence. 2017;11:1745-1753.
https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/. Accessed October 12, 2019.
Ekwunife O, Ezenduka C, Uzoma B. Evaluating the sensitivity of EQ-5D in a sample of patients with type 2 diabetes mellitus in two tertiary health care facilities in Nigeria. BMC Res Notes. 2016;9(1):1-5.
Hilliard P, Funk S, Zourikins N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006;12(5):518-525.
Fischer K, de Kleijn P. Using the Haemophilia Joint Health Score for assessment of teenagers and young adults: exploring reliability and validity. Haemophilia. 2013;19(6):944-950.
Sun J, Hilliard P, Feldman B, et al. Chinese Hemophilia Joint Health Score 2.1 reliability study. Haemophilia. 2014;20(3):435-440.
Varaklioti A, Kontodimopoulos N, Katsarou O, Niakas D. Psychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients. Biomed Res Int. 2014;968081.
Ferreira A, Leite I, Bustamante-Teixeira M, et al. Health-related quality of life in hemophilia: results of the Hemophilia-Specific Quality of Life Index (Haem-a-Qol) at a Brazilian blood center. Rev Bras Hematol Hemoter. 2013;35(5):314-318.
Price V, Klaassen R, Bolton-Maggs P, et al. Measuring disease-specific quality of life in rare populations: a practical approach to cross-cultural translation. Health Qual Life Outcomes. 2009;7:1-8.
Jobe JB. Cognitive psychology and self-reports: models and methods. Qual Life Res. 2003;1:219-227.
Streiner D, Norman G, Cairney J. Health measurement scales: a practical guide to their development and use. Aust NZJ Public Health. 2016;40(3):294-295.
Nunnally J, Bernstein I. Psychometric Theory, 3rd ed. New York, NY: McGraw-Hill; 1994.
Mercan A, Sarper N, Inanir M, et al. Hemophilia-Specific Quality of Life Index (Haemo-QoL and Haem-A-QoL questionnaires) of children and adults: result of a single center from Turkey. Pediatr Hematol Oncol. 2010;27(6):449-461.
World Federation of Hemophilia (WFH). World Federation of Hemophilia Report on the annual Global Survey 2010. https://www1.wfh.org/publication/files/pdf-1427.pdf. Accessed October 15, 2019.

Auteurs

Catherine Lambert (C)

Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

N'Dogomo Meité (N)

Division of Clinical Hematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.

Ibrahima Sanogo (I)

Division of Clinical Hematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.

Sébastien Lobet (S)

Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Division of Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Secteur des Sciences de la Santé, Institut de Recherche Expérimentale et Clinique, Neuromusculoskeletal Lab, Université Catholique de Louvain, Brussels, Belgium.

Sylvia von Mackensen (S)

Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Cedric Hermans (C)

Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH